Fibrin and protein debris

Fibrin and protein debris represent the non-viable biological material found in blood clots and chronic wounds. Fibrin is a fibrous, non-globular protein involved in the clotting of blood, formed by the action of the protease thrombin on fibrinogen, which then polymerizes to form a mesh that creates a hemostatic plug [1]. Protein debris, often referred to as slough or necrotic tissue, consists of dead cells and extracellular matrix components that accumulate in chronic wounds, providing a medium for bacterial growth and physically obstructing the migration of healthy cells [2]. In clinical practice, these materials are targeted by fibrinolytic and debriding agents to restore blood flow or promote wound healing. Fibrinolytic drugs like alteplase work by converting plasminogen to plasmin, which then degrades the fibrin matrix in conditions like myocardial infarction or stroke [3]. Topical debriding enzymes, such as collagenase, specifically digest the proteinaceous anchors of necrotic debris, facilitating its removal without damaging healthy granulation tissue [4]. Sources: [1] StatPearls, Physiology, Fibrinogen; [2] NIH/NCBI, Wound Debridement; [3] Mayo Clinic, Thrombolytic therapy; [4] FDA, Santyl (collagenase) prescribing information.

Other names

Fibrinous exudateNecrotic tissueSloughThrombusBlood clotEscharNon-viable tissue

Enzymatic proteolysis and fibrinolysis; drugs act as exogenous proteases or activate endogenous plasmin to catalyze the breakdown of fibrin polymers and denatured protein structures into soluble fragments.